British American Tobacco

Media

Latest news and features

Honoured again for workforce transparency

Award acknowledges our digital transformation

Contact the press office

Notes to editors

About BAT
BAT is a leading, multi-category consumer goods business with a purpose to build A Better Tomorrow by reducing the health impact of its business through offering a greater choice of enjoyable and less risky products for consumers. The company continues to be clear that combustible cigarettes pose serious health risks, and the only way to avoid these risks is not to start or to quit. BAT encourages those who otherwise continue to smoke to switch completely to scientifically-substantiated, reduced-risk alternatives. In order to deliver this, BAT is transforming into a truly consumer-centric multi-category consumer products business. BAT’s ambition is to have 50 million consumers of its non-combustible products by 2030 and to generate £5billion of New Categories revenue by 2025. BAT has set stretching ESG targets including achieving carbon neutrality for Scopes 1 & 2 by 2030 and eliminating unnecessary single-use plastic and making all plastic packaging reusable, recyclable or compostable by 2025. BAT employs over 55,000 people and operates in over 180 countries, with 11 million points of sale and 45 factories in 43 markets. The company’s Strategic Portfolio is made up of its global cigarette brands and a growing range of reduced-risk*† New Category products. These include vapour, tobacco heating products, modern oral products including tobacco-free nicotine pouches, as well as traditional oral products such as snus and moist snuff. In 2020, we had 13.5 million consumers of our non-combustible products, a rise of 3 million on the year before. The BAT Group generated revenue of £25.8 billion in 2020 and profit from operations of £9.9 billion.

* Based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk free and are addictive.
† Our products as sold in the US, including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to FDA regulation and no reduced-risk claims will be made as to these products without agency clearance.